Kinard David S 4
4 · Elanco Animal Health Inc · Filed Mar 5, 2024
Insider Transaction Report
Form 4
Kinard David S
SEE REMARKS
Transactions
- Award
Common Stock
2024-03-01+15,596→ 155,377 total - Tax Payment
Common Stock
2024-03-01$16.03/sh−5,731$91,868→ 149,646 total - Award
Employee Stock Option(right to buy)
2024-03-01+34,014→ 34,014 totalExercise: $16.03Exp: 2034-03-01→ Common Stock (34,014 underlying)
Footnotes (3)
- [F1]Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
- [F2]Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
- [F3]Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.